HB 1022Just filedInsurance & financial services
Requires insurers to count drug cost reductions, like coupons, toward patients' deductibles and limits
Filed by
Venton JonesDDemocrat· House District 100· Filed Nov 10, 2026The short version · AI summary
Health plan issuers, pharmacy benefit managers and their subcontractors would have to count any reduction in a patient's out-of-pocket drug costs made on the patient's behalf toward the deductible, copayment, cost-sharing or out-of-pocket maximum. This applies to drugs in an essential health benefit category under federal law, even if the plan does not label them that way. Existing rules limit when such reductions count for some drugs. The change applies to plans delivered, issued or renewed on or after January 1, 2028.
What it means for you
If you use a drug with outside help paying, such as a manufacturer coupon, that help could count toward your deductible and yearly spending limit. This could reach those limits sooner. It applies to plans starting in 2028.
One email when it moves, at most one a day. Unsubscribe in one click from any email.